Sign In
Buy DXCM
$72.77
-0.680 (-0.93%)
At Close: Jun 03, 2026
The 3 Best Growth Stocks to Buy in January 2024
08:40am, Sunday, 14'th Jan 2024
Growth stocks are the best way to compound your portfolio. After all, growth has outperformed value since 2010 by a huge margin.
DexCom (DXCM) Preliminary Q4 Revenues Ride on Sensor Demand
11:16am, Tuesday, 09'th Jan 2024
DexCom's (DXCM) revenue growth in the fourth quarter is likely to have been boosted by strong demand for its CGM sensors across the globe. It delivers robust revenue guidance for 2024.
2 Growth Stocks That Could Make You Richer in 2024 and Beyond
07:15am, Tuesday, 09'th Jan 2024
Sarepta Therapeutics boasts excellent innovative abilities and a deep pipeline. DexCom still has a huge growth runway left in the continuous glucose monitoring market.
3 Stocks to Capitalize on the Telehealth Explosion
04:22pm, Monday, 08'th Jan 2024
The COVID-19 pandemic highlighted the sometimes fragile nature of the American healthcare system. Many people had to delay elective surgeries and forego other treatments for an extended period.
Here's Why DexCom (DXCM) is a Strong Growth Stock
11:22am, Monday, 08'th Jan 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Wearable Technology Market Gains Ground, 3 Stocks in Focus
09:46am, Monday, 08'th Jan 2024
In the wearable medical devices industry, investors can keep a keen eye on stocks such as ABT, MDT and DXCM.
DexCom (DXCM) Exceeds Market Returns: Some Facts to Consider
07:34pm, Friday, 05'th Jan 2024
DexCom (DXCM) closed at $123.98 in the latest trading session, marking a +1.76% move from the prior day.
3 Medical-Device Stocks Could Click in 2024
02:30pm, Tuesday, 26'th Dec 2023
Baird is bullish on Boston Scientific, Insulet, and DexCom, stocks set to benefit as those companies ramp up sales.
5 MedTech Stocks Poised to Continue Their Winning Streaks in 2024
12:46pm, Tuesday, 26'th Dec 2023
Stocks like DexCom Inc. (DXCM), Integer Holdings (ITGR), Penumbra (PEN), Haemonetics (HAE), Health Equity (HAE) and are likely to continue their strong performance in 2024.
Play Potential Earnings Beat With 5 Top-Ranked Stocks
09:01am, Tuesday, 26'th Dec 2023
These top-ranked stocks are likely to beat on the bottom line in their upcoming releases. Tap Amazon.com (AMZN), Deckers Outdoor (DECK), Wingstop (WING), DexCom (DXCM) and NVIDIA (NVDA).
DexCom (DXCM) Stock Falls Amid Market Uptick: What Investors Need to Know
07:33pm, Friday, 22'nd Dec 2023
In the closing of the recent trading day, DexCom (DXCM) stood at $122.17, denoting a -0.51% change from the preceding trading day.
3 Reasons Why Growth Investors Shouldn't Overlook DexCom (DXCM)
02:17pm, Friday, 22'nd Dec 2023
DexCom (DXCM) is well positioned to outperform the market, as it exhibits above-average growth in financials.
DexCom's (DXCM) G7 CGM Connects With Tandem's Insulin Pump
03:02pm, Tuesday, 19'th Dec 2023
Dexcom's (DXCM) G7 integrates with Tandem's t:slim X2, revolutionizing diabetes care. A perfect combination of accuracy and innovation, this synergy sets a new standard in continuous glucose monitorin
Dexcom to Present at 42nd Annual J.P. Morgan Healthcare Conference
08:30am, Tuesday, 19'th Dec 2023
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that Kevin Sayer, Chairman, President and Chief Executive Officer, will present an update on the company at the 42nd annual J.P.
Reasons to Add DexCom (DXCM) Stock to Your Portfolio Now
01:32pm, Monday, 18'th Dec 2023
DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.
